The panel will deliberate which high-risk groups should get a booster shot.
Coadministration of COVID-19, influenza vaccines seems effective
Nov 09, 2023
The researchers found that the incidence rates of emergency department or urgent care encounters and outpatient visits were slightly higher for the coadministration group versus the BNT162b2-biv-only group...
J&J to ask FDA to approve its COVID-19 booster shot
Oct 04, 2021
Although the request has yet to be submitted, the FDA on Friday scheduled an Oct. 15 meeting of its expert advisory panel to discuss whether a booster shot of the vaccine should receive emergency use authorization.
First needle-free COVID-19 vaccines receive approval in India, China
Sep 07, 2022
Nasal and inhaled vaccines place doses directly where the virus enters the body, such as in the nose or mouth.
For dialysis recipients, antibody response lowest with Ad26.COV2.S
Oct 27, 2021
Ad26.COV2.S is the Johnson & Johnson vaccine against COVID-19. Patients receiving the attenuated adenovirus vaccine are more likely to have no seroconversion and no detectable or diminished IgG response.
COVID-19 hospitalization rates higher in unvaccinated during omicron
Sep 14, 2022
Hospitalization rates were 2.5 times higher for vaccinated patients without booster versus those with a booster.
FDA advisers weigh COVID-19 booster shots for fall
Apr 07, 2022
Vaccine experts are still guessing at what the ever-changing pandemic will bring.
Pfizer-BioNTech COVID-19 vaccine receives full FDA approval
Aug 23, 2021
The vaccine will now be marketed as Comirnaty and is fully approved for the prevention of COVID-19 in individuals 16 years and older.
COVID-19 cases surge again in U.S. nursing homes
Jan 18, 2022
During the week ending Jan. 9, U.S. nursing homes reported more than 32,000 cases and 645 deaths among their residents.
FDA authorizes spring COVID-19 booster for certain Americans
Apr 18, 2023
Seniors aged 65 years and older can get a booster at least four months following their first dose of the bivalent vaccine.